Graziella Pellegrini

Director, Cell Therapy Programme, Centre for Regenerative Medicine “Stefano Ferrari,” University of Modena and Reggio Emilia

Holocar, the first ATMP containing stem cells to be approved by the European Commission was produced by Graziella and her team. She believes that a focused and cohesive team is the key to success. In the last five years, she improved her attitude to work in multidisciplinary groups of specialists to develop more ambitious and complex therapeutic approaches.

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019